Counties Manukau, in common with the rest of New Zealand, is experiencing a rapid increase in the number of cases of Carbapenemase-producing Enterobacteriaceae (CPE) detected.
Our goal is to protect patients accessing services at CM Health from being colonised or infected by these organisms.
With the rapid importation of CPE organisms into the Counties Manukau area, from countries such as India and Fiji, the risk of exposure to these organisms increases, along with a related rise in the risk of severe morbidity.
This risk has an operational impact, through a rise in demand for single rooms and theatre delays. Our aim is to better this demand and improve identification of patients with CPE who are scheduled for theatre.
The following image is of a sample screening surveillance report.
The rates of CPE continue to increase, especially in the community. Screening compliance has been patchy. Trends in CPE incidence will be shown through monthly reporting.
To date, around 3000 NHI warnings have been removed.
An outbreak at the beginning of 2018 was successfully contained, as was an outbreak in the Transmission Risk Area in November 2018.
Due to the high rate of CPE importation into our area, it is difficult to assess the overall effect that our efforts are having on CPE carriage in CM Health. However, our efforts to protect patients from acquiring CPE will be ongoing and incremental.